Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Cytometry A ; 85(7): 588-600, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24804957

RESUMEN

Previously, we showed that treating macrophages with ATP impairs the intracellular growth of Leishmania amazonensis, and that the P2X7 purinergic receptor is overexpressed during leishmaniasis. In the present study, we directly evaluated the effect of periodate-oxidized ATP (oATP) on parasite control in Leishmania-infected macrophages. We found that oATP impaired the attachment/entrance of L. amazonensis promastigotes to C57BL/6 mouse macrophages in a P2X7 receptor-independent manner, as macrophages from P2X7(-/-) mice were similarly affected. Although oATP directly inhibited the growth of axenic promastigotes in culture, promoted rapid ultrastructural alterations, and impaired Leishmania internalization by macrophages, it did not affect intracellular parasite multiplication. Upon infection, phagosomal acidification was diminished in oATP-treated macrophages, accompanied by reduced endosomal proteolysis. Likewise, MHC class II molecules expression and ectoATPase activity was decreased by oATP added to macrophages at the time of parasite infection. These inhibitory effects were not due to a cytotoxic effect, as no additional release of lactate dehydrogenase was detected in culture supernatants. Moreover, the capacity of macrophages to produce nitric oxide and reactive oxygen species was not affected by the presence of oATP during infection. We conclude that oATP directly affects extracellular parasite integrity and macrophage functioning.


Asunto(s)
Adenosina Trifosfato/análogos & derivados , Leishmaniasis/tratamiento farmacológico , Leishmaniasis/inmunología , Macrófagos/inmunología , Receptores Purinérgicos P2X7/genética , Adenosina Trifosfato/farmacología , Animales , Células de la Médula Ósea/citología , Células de la Médula Ósea/inmunología , Células de la Médula Ósea/parasitología , Antígenos de Histocompatibilidad Clase II/biosíntesis , L-Lactato Deshidrogenasa/metabolismo , Leishmania/inmunología , Leishmaniasis/parasitología , Macrófagos/parasitología , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Óxido Nítrico/biosíntesis , Especies Reactivas de Oxígeno/metabolismo
2.
Appl Microbiol Biotechnol ; 79(1): 97-103, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-18330565

RESUMEN

Microbial colonization of petroleum industry systems takes place through the formation of biofilms, and can result in biodeterioration of the metal surfaces. In a previous study, two oil reservoir Bacillus strains (Bacillus licheniformis T6-5 and Bacillus firmus H(2)O-1) were shown to produce antimicrobial substances (AMS) active against different Bacillus strains and a consortium of sulfate-reducing bacteria (SRB) on solid medium. However, neither their ability to form biofilms nor the effect of the AMS on biofilm formation was adequately addressed. Therefore, here, we report that three Bacillus strains (Bacillus pumilus LF4 -- used as an indicator strain, B. licheniformis T6-5, and B. firmus H(2)O-1), and an oil reservoir SRB consortium (T6lab) were grown as biofilms on glass surfaces. The AMS produced by strains T6-5 and H(2)O-1 prevented the formation of B. pumilus LF4 biofilm and also eliminated pre-established LF4 biofilm. In addition, the presence of AMS produced by H(2)O-1 reduced the viability and attachment of the SRB consortium biofilm by an order of magnitude. Our results suggest that the AMS produced by Bacillus strains T6-5 and H(2)O-1 may have a potential for pipeline-cleaning technologies to inhibit biofilm formation and consequently reduce biocorrosion.


Asunto(s)
Antibacterianos/farmacología , Bacillus/metabolismo , Biopelículas/efectos de los fármacos , Petróleo/microbiología , Antibacterianos/biosíntesis , Biopelículas/crecimiento & desarrollo , Vidrio , Viabilidad Microbiana , Microscopía Confocal , Microscopía Electrónica de Rastreo , Bacterias Reductoras del Azufre/efectos de los fármacos
3.
J Appl Microbiol ; 98(3): 667-75, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-15715870

RESUMEN

AIMS: Forty Bacillus strains isolated from a Brazilian oil reservoir were tested against each other to select strains producing antimicrobial substances (AMS). Three strains, Bacillus subtilis (LFE-1), Bacillus firmus (H2O-1) and Bacillus licheniformis (T6-5), were selected due to their ability to inhibit more than 65% of the Bacillus strains tested. These three strains were also investigated for their capability to inhibit sulphate-reducing bacteria (SRB). Furthermore, physiological and biochemical characteristics of the antimicrobial compounds produced by the selected strains were determined. METHODS AND RESULTS: Among the forty strains tested, 36 (90%) strains were able to inhibit at least one Bacillus strain used as indicator in plate assays and three of them (LFE-1, T6-5 and H2O-1) were able to inhibit 65, 70 and 97.5% of the 40 strains studied here respectively. Clear zones of inhibition were observed when H2O-1 was tested against SRB-containing consortium T6-lab and Desulfovibrio alaskensis strain NCIMB 13491, while strain T6-5 was able to inhibit only the D. alaskensis strain. The three substances showed to be insensitive to different enzymes and chemicals, were heat stable and the substances produced by strains T6-5 and H2O-1 were active over a wide pH range. CONCLUSIONS: Three different AMS produced by Bacillus strains from an oil reservoir, two of them with activity against SRB, are presented here. SIGNIFICANCE AND IMPACT OF THE STUDY: The preliminary characterization of these AMS points to their potential use as biocides in the petroleum industry for controlling problems associated with SRB.


Asunto(s)
Bacillus subtilis/metabolismo , Bacteriocinas/biosíntesis , Microbiología Industrial , Petróleo , Bacillus/crecimiento & desarrollo , Bacillus/aislamiento & purificación , Bacillus/metabolismo , Bacillus subtilis/crecimiento & desarrollo , Bacillus subtilis/aislamiento & purificación , Reactores Biológicos , Brasil , Electroforesis en Gel de Poliacrilamida , Calor , Concentración de Iones de Hidrógeno , Pruebas de Sensibilidad Microbiana , Especificidad de la Especie , Bacterias Reductoras del Azufre
4.
Infect Immun ; 70(9): 5115-23, 2002 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-12183561

RESUMEN

Trypanosoma cruzi proteinases are involved in host cell invasion in human patients and in mouse models. In mice, murine alpha(2)-macroglobulin (MAM) and murinoglobulin are circulating plasma proteinase inhibitors that also have important roles in inflammation and immune modulation. To define their role in experimental Chagas disease, we investigated the susceptibility to T. cruzi infection of mice that are deficient only in alpha2-macroglobulins (AM-KO) or in both MAM and monomeric murinoglobulin-1 (MM-KO), relative to the wild type (WT). Despite the high parasite load, parasitemia was lower in AM-KO and MM-KO mice than in WT mice. Nevertheless, we observed a significantly higher parasite load in the hearts of AM-KO and MM-KO mice, i.e., more amastigote nests and inflammatory infiltrates than in WT mice. This result demonstrates a protective role for MAM in the acute phase of murine T. cruzi infection. We further demonstrated in vitro that human alpha2-macroglobulins altered the trypomastigote morphology and motility in a dose-dependent way, and that also impaired T. cruzi invasion in cardiomyocytes. Finally, we demonstrated that the levels of transforming growth factor beta in AM-KO mice increased significantly in the third week postinfection, concomitant with high amastigote burden and important fibrosis. Combined, these in vivo and in vitro findings demonstrate that the MAM contribute to the resistance of mice to acute myocarditis induced by experimental T. cruzi infection.


Asunto(s)
Cardiomiopatía Chagásica/etiología , Enfermedad de Chagas/etiología , Miocardio/patología , Factor de Crecimiento Transformador beta/sangre , Trypanosoma cruzi/patogenicidad , alfa-Macroglobulinas/deficiencia , Animales , Cardiomiopatía Chagásica/inmunología , Cardiomiopatía Chagásica/parasitología , Cardiomiopatía Chagásica/patología , Enfermedad de Chagas/inmunología , Enfermedad de Chagas/parasitología , Enfermedad de Chagas/patología , Endopeptidasas/fisiología , Femenino , Fibrosis , Humanos , Técnicas In Vitro , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Inhibidores de Proteasas/sangre , Seroglobulinas/deficiencia , Seroglobulinas/genética , Trypanosoma cruzi/efectos de los fármacos , Trypanosoma cruzi/enzimología , alfa-Macroglobulinas/genética , alfa-Macroglobulinas/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...